Kindred Healthcare lowers FY13 EPS view to $1.10-$1.30 from prior $1.20-$1.40 FY13 consensus is $1.27. Kindred Healthcare announced revised earnings guidance for the year ended December 31, 2013 as a result of certain Medicare reimbursement changes included in the recently enacted American Taxpayer Relief Act of 2012.
News For KND From The Last 14 Days
Check below for free stories on KND the last two weeks.
Kindred Healthcare upgraded to Market Perform from Underperform at Wells Fargo Wells Fargo upgraded Kindred Healthcare to Market Perform as it believes significant risks to reimbursement for long term acute care hospitals has subsided. The firm raised its price target range for shares to $18-$21 from $10-$13.